Alpine Immune Sciences Investor Relations Material
Latest events
Study Update
Alpine Immune Sciences
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Alpine Immune Sciences Inc
Access all reports
Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. The Company's lead product candidate, ALP-001 (Tocagen's AGS-003), an ADCC-enhancing therapeutic candidate for EGFRvIII+ glioma patients, is being developed in collaboration with Tocagen Inc., under an exclusive license from Transgene S.A.
Key slides for Alpine Immune Sciences Inc
Study Update
Alpine Immune Sciences Inc
Study Update
Alpine Immune Sciences Inc
Latest articles
Larry Page: The Mastermind Behind Google
Explore the journey of Larry Page from a tech-savvy youth to co-founding Google and leading Alphabet.
24 Apr 2024
Mark Leonard: The Mysterious Brain Behind Constellation Software
Information about Mark Leonard is scarce, and one of the only ways to “get to know” him is through his shareholder letters. Join us in an attempt to do so.
24 Apr 2024
Sundar Pichai: CEO of Alphabet and Google
Explore Sundar Pichai's improbable journey from Chennai, India, to becoming one of the most powerful individuals on the planet.
19 Apr 2024
Ticker symbol
Country
🇺🇸 United States